Antara Care Homes has introduced ExoAtlet II, a robotic-assisted exoskeleton, at its Bannerghatta centre in Bengaluru to enhance rehabilitation for patients recovering from stroke, paralysis, and neurological conditions. The addition of this technology, alongside a robotic device for hand and finger retraining, positions the facility among the few transition care centres in India offering robotic-assisted recovery. This development strengthens the specialist-led rehabilitation programme managed by Antara Assisted Care Services, a wholly owned subsidiary of Max India .

The ExoAtlet II is a wearable robotic suit designed to fit around a patient's legs and hips, facilitating hundreds of consistent, physiologically accurate steps per session. This level of repetition is often difficult to sustain through manual therapy alone. The integration of such advanced technology aims to improve limb function, reduce complications, and enhance the overall quality of life for patients by providing structured and timely rehabilitation.

Technology and Clinical Application

Ishaan Khanna, CEO of Antara Assisted Care Services, highlighted the growing burden of stroke and neurological disorders in India, noting that an estimated 347 million people are projected to be senior citizens by 2050. He emphasized that robotic-assisted gait training systems are known to enhance clinical outcomes, helping patients regain functional independence and confidence during recovery.

Lt Col (Dr) Faisal Husain, Medical Superintendent at Antara Assisted Care Services, explained that successful rehabilitation relies on personalization, repetition, and consistency. Each patient's recovery plan is designed by a rehabilitation-medicine specialist and executed by a trained physiotherapy team. When indicated, the exoskeleton's settings are calibrated to individual needs and progressed as the patient improves, working in tandem with hands-on physiotherapy.

Service Footprint

Antara Care Homes operates across Delhi-NCR, Bengaluru, and Chennai, providing rehabilitation and transition care for individuals recovering from hospitalization, surgery, illness, or injury. The Bengaluru facility distinguishes itself by having every patient journey designed and led by a Physical Medicine and Rehabilitation (PM&R) doctor. The multidisciplinary team includes physiotherapy, occupational therapy, speech and swallow therapy, and psychologist-led cognitive care, supported by round-the-clock clinical and nursing supervision.

The therapy facility is equipped for the full spectrum of recovery, ranging from neuromuscular re-education to strength and balance training. It houses two robotic tools: a device for fine hand and finger movement retraining and the newly added ExoAtlet II for lower-limb and gait recovery.

Max India Limited announced that its shareholders have approved the appointment of Ms. Mrinalini Mirchandani as an Independent Director and the reallocation of unutilised proceeds from a rights issue. The resolutions were passed through a postal ballot process that concluded on July 12, 2026, with the requisite majority required under the Companies Act, 2013, and SEBI LODR Regulations.

The postal ballot sought shareholder consent on two special resolutions. The first resolution concerned the appointment of Ms. Mrinalini Mirchandani (DIN: 11619010) as an Independent Director (Non-Executive) for a term of five consecutive years. The second resolution sought approval for the reallocation of the unutilised portion of the proceeds from the rights issue of fully paid-up equity shares offered to eligible equity shareholders.

The remote e-voting process commenced on June 13, 2026, and concluded on July 12, 2026. Kapil Dev Taneja, Partner of M/s Sanjay Grover & Associates, served as the Scrutinizer for the process. The total paid-up share capital of the company as on the cut-off date of June 5, 2026, was INR 52,52,28,620, divided into 5,25,22,862 equity shares of INR 10 each.

Voting Results

A total of 3,09,33,950 valid votes were cast via remote e-voting. The detailed results for the resolutions are as follows:

The breakdown of voting participation by shareholder category indicates significant engagement from the Promoter and Promoter Group, which held 26,169,300 shares. Public Institutions held 4,555,976 shares, while Public Non-Institutions held 21,797,586 shares. The resolutions were deemed passed on July 12, 2026, the last date of remote e-voting.